NCT00307060View on ClinicalTrials.gov

MK0954A-264 Filter Study (0954A-264)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

274

Participants

Timeline

Start Date

December 1, 2004

Primary Completion Date

June 1, 2005

Study Completion Date

June 2, 2005

Conditions
Mild to Severe Hypertension
Interventions
DRUG

MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 6 weeks

DRUG

losartan / Duration of Treatment: 6 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00307060 - MK0954A-264 Filter Study (0954A-264)(COMPLETED) | Biotech Hunter | Biotech Hunter